Influence of iodine-131 dose on the outcome of hyperthyroidism in children

Pediatrics

Volumn 111, Issue 4, 2003, Pages 745-749

  Rivkees, Scott A ^a   Cornelius, Eugene A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Graves' disease; Hyperthyroidism; Radioactive iodine; Thyroid

Indexed keywords

IODINE 131;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; GRAVES DISEASE; HUMAN; LONG TERM CARE; MALE; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIATION DOSE; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; IODINE RADIOISOTOPES; MALE; RADIOTHERAPY DOSAGE; THYROID GLAND; TREATMENT OUTCOME;

EID: 0037383225     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.111.4.745     Document Type: Article

References (37)

1. Zimmerman D, Lteif AN. Thyrotoxicosis in children. Endocrinol Metab Clin North Am. 1998;27:109-126
2. LeFranchi S, Mandel SH. Graves' disease in the neonatal period and childhood. In: Braverman LE, Utiger RD, eds. Clinical Text. Philidelphia, PA: Lippincott; 1995;1237-1246
3. Fisher DA. Graves' disease in children. Curr Ther Endocrinol Metab. 1994;5:71-74
4. Hamburger JI. Management of hyperthyroidism in children and adolescents. J Clin Endocrinol Metab. 1985;60:1019-1024
5. Lazar L, Kalter-Leibovici O, Pertzelan A, Weintrob N, Josefsberg Z, Phillip M. Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal patients. J Clin Endocrinol Metab. 2000;85:3678-3682
6. Shulman DI, Muhar I, Jorgensen EV, Diamond FB, Bercu BB, Root AW. Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy. Thyroid. 1997;7:755-760
7. Rivkees SA, Sklar C, Freemark M. Clinical review 99: the management of Graves' disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab. 1998;83:3767-3776
8. Chapman EM. History of the discovery and early use of radioactive iodine. JAMA. 1983;250:2042-2044
9. Starr P, Jaffe HL, Oettinger L Jr. Later results of 131-I treatment of hyperthyroidism in 73 children and adolescence: 1967 follow-up. J Nucl Med. 1969;10:586-590
10. Kogut MD, Kaplan SA, Cotlipp PJ, Tiamsic T, Boyle D. Treatment of hyperthyroidism in children: analysis of forty-five patients. N Engl J Med. 1965;272:217-222
11. Crile G, Schumacher OP. Radioactive iodine treatment of Graves' disease: results in 32 children under 16 years of age. Am J Dis Child. 1965;110:501-504
12. Hayek A, Chapman EM, Crawford JD. Long term results of treatment of thyrotoxicosis in children and adolescents with radioactive iodine (131I) for hyperthyroidism. N Engl J Med. 1970;283:949-953
13. Safa AM. Treatment of hyperthyroidism with a large initial dose of sodium iodine I 131. Arch Intern Med. 1975;135:673-675
14. Safa AM, Schumacher OP, Rodriguez-Antunez A. Long-term follow-up results in children and adolescents treated with radioactive iodine (131I) for hyperthyroidism. N Engl J Med. 1975;292:167-171
15. Levy WM, Schumacher OP, Gupta M. Treatment of childhood Graves' disease: a review with emphasis on radioiodine treatment. Cleve Clin J Med. 1988;55:373-382
16. Clark JD, Gelfand MJ, Elgazzar AH. Iodine-131 therapy of hyperthyroidism in pediatric patients. J Nucl Med. 1995;36:442-445
17. Freitas JE, Swanson DP, Gross MD, Sisson JC. Iodine131-I: optimal therapy for thyroidism in children and adolescents? J Nucl Med. 1979;20:847-850
18. Peters H, Fischer C, Bogner U, Reiners C, Schleusener H. Treatment of Graves' hyperthyroidism with radioiodine: results of a prospective randomized study. Thyroid. 1997;7:247-251
19. Starr P, Jaffe HL, Oettinger L Jr. Late results of 131I treatment of hyperthyroidism in 73 children and adoloscents. J Nucl Med. 1964;5:81-89
20. Quimby EM, Feitelberg S, Gross W. Radioactive Nuclides in Medicine and Biology. Lea and Febigir; 1970
21. Peters H, Fischer C, Bogner U, Reiners C, Schleusener H. Radioiodine therapy of Graves' hyperthyroidism: standard vs. calculated 131 iodine activity: results from a prospective, randomized, multicentre study. Eur J Clin Invest. 1995;25:186-193
22. Peters H, Fischer C, Bogner U, Reiners C, Schleusener H. Reduction in thyroid volume after radioiodine therapy of Graves' hyperthyroidism: results of a prospective, randomized, multicentre study. Eur J Clin Invest. 1996;26:59-63
23. Ron E, Doody MM, Becker DV, et al. Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. JAMA. 1998;280:347-355
24. Dobyns BM, Sheline GE, Workman JB, Tompkins EA, McConahey WM, Becker DV. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the Cooperative Thyrotoxicosis Therapy Follow-up Study. J Clin Endocrinol Metab. 1974;38:976-998
25. Sheline GE, McCormack KR, Galante M. Thyroid nodules occurring late after treatment of thryotoxicosis with radioiodine. J Clin Endocrinol Metab. 1962;22:8-17
26. Farbota LM, Calandra DB, Lawrence AM, Paloyan E. Thyroid carcinoma in Graves' disease. Surgery. 1985;98:1148-1153
27. Karlan MS, Pollock WF, Synder WH. Carcinoma of the thyroid following treatment of hyperthyroidism with radioactive iodine. Calif Med. 1965;101:196-201
28. Shore RE. Issues and epidemiological evidence regarding radiation-induced thyroid cancer. Radiat Res. 1992;131:98-111
29. Gorman CA, Robertson JS. Radiation dose in the selection of 131I or surgical treatment for toxic thyroid adenoma. Ann Intern Med. 1978;89:85-90
30. Mazzaferri EL. Thyroid cancer and Graves' disease: the controversy ten years later. Endocr Pract. 2000;6:221-225
31. Goolden AWG, Davey JB. The ablation of normal thyroid tissue with iodine-131. Br J Radiol. 1963;36:340-345
32. Vitti P, Rago T, Chiovato L, et al. Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment. Thyroid. 1997;7:369-375
33. Toohey RE, Stabin MG. Comparative analysis of dosimetry parameters for nuclear medicine. ORISE Report 99-1064, 1999. In: Proceedings of the Sixth International Radiopharmaceutical Dosimetry Symposium; Gatlinburg, TN; 1996:532-551
34. Toohey RE, Stabin MG, Watson EE. The AAPM/RSNA physics tutorial for residents: internal radiation dosimetry: principles and applications. Radiographics. 2000;20:533-546
35. Committee on Health Effects of Exposure to Low Levels of Ionizing Radiations (Beir VII) NRC. Health Effects of Exposure to Low Levels of Ionizing Radiations: Time for Reassessment? Washington, DC: National Academy of Science; 1998
36. Hendee WR. Estimation of radiation risks: BEIR V and its significance for medicine. JAMA. 1992;268:620-624
37. Committee on the Biological Effects of Ionizing Radiation (BEIR V) NRC. Health Effects of Exposure to Low Levels of Ionizing Radiation: BEIR V. Washington DC: National Academy Press; 1990